Organs involved
Brain areas affected
Functions affected
Processes affected
Social issues
Prone countries
Denmark, Sweden, Germany, Ireland, Singapore, Australia, Netherlands, Belgium, Finland, Liechtenstein, United Kingdom, New Zealand, United Arab Emirates, Canada, Korea (Republic of), Luxembourg, United States, Austria, Slovenia, Japan, Israel, Malta, Spain, France, Cyprus, Italy, Estonia, Czechia, Greece, Bahrain, Andorra, Poland, Latvia, Lithuania, Croatia, Qatar, Saudi Arabia, Portugal, San Marino, Chile, Slovakia, Türkiye, Hungary, Argentina, Kuwait, Montenegro, Saint Kitts and Nevis, Uruguay, Romania, Antigua and Barbuda, Brunei Darussalam, Russian Federation, Bahamas, Panama, Oman, Georgia, Trinidad and Tobago, Barbados, Malaysia, Costa Rica, Serbia, Thailand, Kazakhstan, Seychelles, Belarus, Bulgaria, Palau, Mauritius, Grenada, Albania, China, Armenia, Mexico, Iran (Islamic Republic of), Sri Lanka, Bosnia and Herzegovina, Saint Vincent and the Grenadines, Dominican Republic, Ecuador, North Macedonia, Cuba, Moldova (Republic of), Maldives, Peru, Azerbaijan, Brazil, Colombia, Libya, Algeria, Turkmenistan, Guyana, Mongolia, Dominica, Tonga, Jordan, Ukraine, Tunisia, Marshall Islands, Paraguay, Fiji, Egypt, Uzbekistan, Viet Nam, Saint Lucia, Lebanon, South Africa, Palestine, Indonesia, Philippines, Botswana, Jamaica, Samoa, Kyrgyzstan, Belize, Venezuela, Bolivia, Morocco, Nauru, Gabon, Suriname, Bhutan, Tajikistan, El Salvador, Iraq, Bangladesh, Nicaragua, Cabo Verde, Tuvalu, Equatorial Guinea, India, Micronesia (Federated States of), Guatemala, Kiribati, Honduras, Lao People's Democratic Republic, Vanuatu, Sao Tome and Principe, Eswatini, Namibia, Myanmar, Ghana, Kenya, Nepal, Cambodia, Congo, Angola, Cameroon, Comoros, Zambia, Papua New Guinea, Timor-Leste, Solomon Islands, Syrian Arab Republic, Haiti, Uganda, Zimbabwe, Nigeria, Rwanda, Togo, Mauritania, Pakistan, Côte d'Ivoire, Tanzania (United Republic of), Lesotho, Senegal, Sudan, Djibouti, Malawi, Benin, Gambia, Eritrea, Ethiopia, Liberia, Madagascar, Guinea-Bissau, Democratic Republic of Congo, Guinea, Afghanistan, Mozambique, Sierra Leone, Burkina Faso, Yemen, Burundi, Mali, Chad, Niger, Central African Republic, South Sudan, Somalia, Democratic People's Rep. of Korea, Monaco, Norway, Iceland, Switzerland
1-(2-pyrimidinyl) piperazine / Controlled substance
Chemical formula: C8H12N4. Molecular weight: 164.21 g/mol. Also known as 1-pp its used in the psychological field to deal with anxiety. Currently available for legal medical uses in the USA and other geopolitical administrations
Corrosive, Irritant substance, Respiratory irritation, Damage/eye irritation, Organ toxicity
- Select one to explore, then click icon
symptoms at least
months at least
Scientific tool
Developed By IOE0919418501
